Literature DB >> 22210225

Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.

Ivan F N Hung, Yotam Levin, Kelvin K W To.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22210225     DOI： 10.1016/j.vaccine.2011.12.069

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  12 in total

Review 1.  Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Authors:  Yotam Levin; Efrat Kochba; Ivan Hung; Richard Kenney
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Immunogenicity, safety and tolerability of intradermal influenza vaccines.

Authors:  Ivan F N Hung; Kwok-Yung Yuen
Journal:  Hum Vaccin Immunother       Date:  2017-07-06       Impact factor: 3.452

3.  A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.

Authors:  Giovanni Della Cioppa; Uwe Nicolay; Kelly Lindert; Geert Leroux-Roels; Frédéric Clement; Flora Castellino; Cristina Galli; Nicola Groth; Yotam Levin; Giuseppe Del Giudice
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

4.  Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.

Authors:  Anna J X Zhang; Can Li; Kelvin K W To; Hou-Shun Zhu; Andrew C Y Lee; Chuan-Gen Li; Jasper F W Chan; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

Review 5.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

6.  High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

Authors:  Kelvin K W To; Anna J X Zhang; Ivan F N Hung; Ting Xu; Whitney C T Ip; Rebecca T Y Wong; Joseph C K Ng; Jasper F W Chan; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2012-05-09

7.  Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.

Authors:  Alexandra C I Depelsenaire; Stefano C Meliga; Celia L McNeilly; Frances E Pearson; Jacob W Coffey; Oscar L Haigh; Christopher J Flaim; Ian H Frazer; Mark A F Kendall
Journal:  J Invest Dermatol       Date:  2014-04-08       Impact factor: 8.551

8.  Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.

Authors:  Hiromasa Okayasu; Carolyn Sein; Diana Chang Blanc; Alejandro Ramirez Gonzalez; Darin Zehrung; Courtney Jarrahian; Grace Macklin; Roland W Sutter
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

9.  Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.

Authors:  Sonia Golombek; Martin Pilz; Heidrun Steinle; Efrat Kochba; Yotam Levin; Dominique Lunter; Christian Schlensak; Hans Peter Wendel; Meltem Avci-Adali
Journal:  Mol Ther Nucleic Acids       Date:  2018-03-14       Impact factor: 8.886

10.  Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes.

Authors:  Efrat Kochba; Yotam Levin; Itamar Raz; Avivit Cahn
Journal:  Diabetes Technol Ther       Date:  2016-08-08       Impact factor: 6.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.